
Researchers at Johns Hopkins University have made a significant stride in early cancer detection. Their study reveals a blood test capable of identifying cancer years before symptoms manifest. By detecting circulating tumor DNA, this innovative approach offers the potential for earlier intervention and improved survival rates, marking a transformative step in cancer diagnostics.